Phase 3 Multiple Sclerosis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are 18 years old or older
- You are about to receive at least your 4th dose of ocrelizumab (given every 6 months)
- You need to have MRI scans as part of your ongoing treatment
- You were originally prescribed ocrelizumab for active, relapsing-remitting, or secondary progressive multiple sclerosis
- You have had no relapses (no new or worsening MS symptoms lasting more than 24 hours) for at least 18 months
- Your level of disability falls within a specific range on the standard MS disability scale (EDSS score between 0 and 6) (confirm with trial site)
- You have been fully informed about the study and have agreed to take part by signing a consent form
- You are able to read and communicate in French
- You are covered by a French social insurance or healthcare scheme
Who may not be able to join:
- You have a form of MS called primary progressive MS
- You are already receiving your ocrelizumab doses spaced 9 months or more apart
- You have a medical reason that prevents you from continuing ocrelizumab, such as a serious allergic reaction, an active infection, a new cancer diagnosis, or a severe immune system problem
- You are planning to become pregnant within the next 3 years
- You are unable to have an MRI scan for any medical reason
- You are unable to receive contrast dye used during MRI scans
- You have serious or poorly controlled problems with your kidneys, liver, blood, digestive system, lungs, mental health, or heart, or any other uncontrolled health condition
- You are under a legal protection order (confirm with trial site)
- You are of childbearing age and do not wish to use effective contraception
- You are currently pregnant or breastfeeding
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +33 148036753
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Absence of radiological disease activity at 2 years
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.